vs
Side-by-side financial comparison of Fat Brands, Inc (FAT) and AMICUS THERAPEUTICS, INC. (FOLD). Click either name above to swap in a different company.
AMICUS THERAPEUTICS, INC. is the larger business by last-quarter revenue ($185.2M vs $140.0M, roughly 1.3× Fat Brands, Inc). AMICUS THERAPEUTICS, INC. runs the higher net margin — 0.9% vs -41.6%, a 42.5% gap on every dollar of revenue. On growth, AMICUS THERAPEUTICS, INC. posted the faster year-over-year revenue change (23.7% vs -2.3%). AMICUS THERAPEUTICS, INC. produced more free cash flow last quarter ($16.0M vs $-16.9M). Over the past eight quarters, AMICUS THERAPEUTICS, INC.'s revenue compounded faster (29.5% CAGR vs -6.1%).
FAT Brands Inc. is an American multi-brand restaurant and sports bar franchise operator headquartered in Beverly Hills, California.
Amicus Therapeutics, Inc. is a public American biopharmaceutical company based in Philadelphia, Pennsylvania. The company went public in 2007 under the Nasdaq trading symbol FOLD. This followed a 2006 planned offering and subsequent withdrawal, which would have established the trading symbol as AMTX Prior to their IPO, Amicus was funded by a variety of venture capital firms including Radius Ventures, Canaan Partners and New Enterprise Associates.
FAT vs FOLD — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $140.0M | $185.2M |
| Net Profit | $-58.2M | $1.7M |
| Gross Margin | — | 85.7% |
| Operating Margin | -12.4% | 8.6% |
| Net Margin | -41.6% | 0.9% |
| Revenue YoY | -2.3% | 23.7% |
| Net Profit YoY | -30.1% | -88.5% |
| EPS (diluted) | $-3.39 | $0.00 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $185.2M | ||
| Q3 25 | $140.0M | $169.1M | ||
| Q2 25 | $146.8M | $154.7M | ||
| Q1 25 | $142.0M | $125.2M | ||
| Q4 24 | $145.3M | $149.7M | ||
| Q3 24 | $143.4M | $141.5M | ||
| Q2 24 | $152.0M | $126.7M | ||
| Q1 24 | $152.0M | $110.4M |
| Q4 25 | — | $1.7M | ||
| Q3 25 | $-58.2M | $17.3M | ||
| Q2 25 | $-54.2M | $-24.4M | ||
| Q1 25 | $-46.0M | $-21.7M | ||
| Q4 24 | $-67.4M | $14.7M | ||
| Q3 24 | $-44.8M | $-6.7M | ||
| Q2 24 | $-39.4M | $-15.7M | ||
| Q1 24 | $-38.3M | $-48.4M |
| Q4 25 | — | 85.7% | ||
| Q3 25 | — | 88.5% | ||
| Q2 25 | — | 90.2% | ||
| Q1 25 | — | 90.7% | ||
| Q4 24 | — | 90.1% | ||
| Q3 24 | — | 90.6% | ||
| Q2 24 | — | 91.1% | ||
| Q1 24 | — | 87.7% |
| Q4 25 | — | 8.6% | ||
| Q3 25 | -12.4% | 20.3% | ||
| Q2 25 | -10.6% | -6.1% | ||
| Q1 25 | -6.0% | -6.3% | ||
| Q4 24 | -27.1% | 10.7% | ||
| Q3 24 | -6.2% | 15.3% | ||
| Q2 24 | -1.8% | 11.8% | ||
| Q1 24 | -0.9% | -25.1% |
| Q4 25 | — | 0.9% | ||
| Q3 25 | -41.6% | 10.2% | ||
| Q2 25 | -36.9% | -15.8% | ||
| Q1 25 | -32.4% | -17.3% | ||
| Q4 24 | -46.4% | 9.8% | ||
| Q3 24 | -31.2% | -4.8% | ||
| Q2 24 | -25.9% | -12.4% | ||
| Q1 24 | -25.2% | -43.9% |
| Q4 25 | — | $0.00 | ||
| Q3 25 | $-3.39 | $0.06 | ||
| Q2 25 | $-3.17 | $-0.08 | ||
| Q1 25 | $-2.73 | $-0.07 | ||
| Q4 24 | $-4.06 | $0.05 | ||
| Q3 24 | $-2.74 | $-0.02 | ||
| Q2 24 | $-2.43 | $-0.05 | ||
| Q1 24 | $-2.37 | $-0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $293.5M |
| Total DebtLower is stronger | $1.3B | $392.7M |
| Stockholders' EquityBook value | $-585.8M | $274.2M |
| Total Assets | $1.2B | $949.9M |
| Debt / EquityLower = less leverage | — | 1.43× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $293.5M | ||
| Q3 25 | — | $263.8M | ||
| Q2 25 | — | $231.0M | ||
| Q1 25 | — | $250.6M | ||
| Q4 24 | — | $249.9M | ||
| Q3 24 | — | $249.8M | ||
| Q2 24 | — | $260.1M | ||
| Q1 24 | — | $239.6M |
| Q4 25 | — | $392.7M | ||
| Q3 25 | $1.3B | $392.0M | ||
| Q2 25 | $1.3B | $391.3M | ||
| Q1 25 | $1.3B | $390.7M | ||
| Q4 24 | $1.3B | $390.1M | ||
| Q3 24 | $1.2B | $389.5M | ||
| Q2 24 | $1.2B | $388.9M | ||
| Q1 24 | $1.2B | $388.4M |
| Q4 25 | — | $274.2M | ||
| Q3 25 | $-585.8M | $230.4M | ||
| Q2 25 | $-536.5M | $204.3M | ||
| Q1 25 | $-493.9M | $193.6M | ||
| Q4 24 | $-455.7M | $194.0M | ||
| Q3 24 | $-386.1M | $178.8M | ||
| Q2 24 | $-338.6M | $132.5M | ||
| Q1 24 | $-296.8M | $130.7M |
| Q4 25 | — | $949.9M | ||
| Q3 25 | $1.2B | $868.8M | ||
| Q2 25 | $1.2B | $815.3M | ||
| Q1 25 | $1.3B | $789.8M | ||
| Q4 24 | $1.3B | $785.0M | ||
| Q3 24 | $1.3B | $786.6M | ||
| Q2 24 | $1.4B | $749.5M | ||
| Q1 24 | $1.4B | $721.8M |
| Q4 25 | — | 1.43× | ||
| Q3 25 | — | 1.70× | ||
| Q2 25 | — | 1.92× | ||
| Q1 25 | — | 2.02× | ||
| Q4 24 | — | 2.01× | ||
| Q3 24 | — | 2.18× | ||
| Q2 24 | — | 2.93× | ||
| Q1 24 | — | 2.97× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-14.5M | $16.3M |
| Free Cash FlowOCF − Capex | $-16.9M | $16.0M |
| FCF MarginFCF / Revenue | -12.1% | 8.6% |
| Capex IntensityCapex / Revenue | 1.7% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 9.62× |
| TTM Free Cash FlowTrailing 4 quarters | $-75.0M | $29.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $16.3M | ||
| Q3 25 | $-14.5M | $35.7M | ||
| Q2 25 | $-26.9M | $-26.5M | ||
| Q1 25 | $-13.2M | $7.8M | ||
| Q4 24 | $-10.4M | $-3.9M | ||
| Q3 24 | $-3.2M | $-23.0M | ||
| Q2 24 | $-14.2M | $22.7M | ||
| Q1 24 | $-28.4M | $-29.7M |
| Q4 25 | — | $16.0M | ||
| Q3 25 | $-16.9M | $35.3M | ||
| Q2 25 | $-29.3M | $-28.9M | ||
| Q1 25 | $-17.8M | $7.5M | ||
| Q4 24 | $-11.0M | $-4.2M | ||
| Q3 24 | $-11.1M | $-23.3M | ||
| Q2 24 | $-24.4M | $21.6M | ||
| Q1 24 | $-32.5M | $-31.5M |
| Q4 25 | — | 8.6% | ||
| Q3 25 | -12.1% | 20.9% | ||
| Q2 25 | -20.0% | -18.7% | ||
| Q1 25 | -12.5% | 6.0% | ||
| Q4 24 | -7.6% | -2.8% | ||
| Q3 24 | -7.7% | -16.5% | ||
| Q2 24 | -16.1% | 17.0% | ||
| Q1 24 | -21.4% | -28.5% |
| Q4 25 | — | 0.2% | ||
| Q3 25 | 1.7% | 0.2% | ||
| Q2 25 | 1.6% | 1.6% | ||
| Q1 25 | 3.2% | 0.2% | ||
| Q4 24 | 0.4% | 0.2% | ||
| Q3 24 | 5.5% | 0.3% | ||
| Q2 24 | 6.7% | 0.9% | ||
| Q1 24 | 2.7% | 1.6% |
| Q4 25 | — | 9.62× | ||
| Q3 25 | — | 2.06× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | -0.27× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
FAT
| Restaurant Sales | $96.6M | 69% |
| Royalty | $21.6M | 15% |
| Factory | $9.6M | 7% |
| Advertising | $9.1M | 7% |
| Franchisor | $1.5M | 1% |
| Other | $1.5M | 1% |
FOLD
| Other | $105.8M | 57% |
| Galafold | $64.8M | 35% |
| Pombiliti Opfolda | $14.6M | 8% |
